Kui Huang

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Clinical Practice

Systemic Sclerosis

Advanced Non Small Cell Lung Cancer

Top Venues

Pharmacoepidemiology and drug safety

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick J Arena, Kui Huang, L Lukas Løfling, Shahram Bahmanyar, Jingping Mo, Stephen E Schachterle, Anthony P Nunes, Elisabeth Smits, Rosa Juuti, Fabian Hoti, Pasi Korhonen, Kasper Adelborg, Jens Sundbøll, Torben Riis Rasmussen, Anders Løkke, Vera Ehrenstein
Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study. Pharmacoepidemiology and drug safety (2022)
Patrick J Arena, Kui Huang, Lukas Löfling, Shahram Bahmanyar, Jingping Mo, Stephen E Schachterle, Anthony P Nunes, Elisabeth Smits, Rosa Juuti, Fabian Hoti, Pasi Korhonen, Kasper Adelborg, Jens Sundbøll, Torben Riis Rasmussen, Anders Løkke, Vera Ehrenstein
Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study. Pharmacoepidemiology and drug safety (2022)
Katherine M Duszynski, James H Stark, Catherine Cohet, Wan-Ting Huang, Ju Young Shin, Edward Chia-Cheng Lai, Kenneth Keng Cheung Man, Nam-Kyong Choi, Alena Khromava, Tomomi Kimura, Kui Huang, Sawaeng Watcharathanakij, Sonali Kochhar, Robert T Chen, Nicole L Pratt
Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety. Pharmacoepidemiology and drug safety 30 (7) (2021)
Vera Ehrenstein, Kui Huang, Johnny Kahlert, Shahram Bahmanyar, Pär Karlsson, L Lukas Løfling, Anthony P Nunes, Cheryl Enger, Irene D Bezemer, Josephina G Kuiper, Fabian Hoti, Rosa Juuti, Pasi Korhonen, Jingping Mo, Stephen E Schachterle, Keith D Wilner, Mikael Rørth, Henrik T Sørensen
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United States. Pharmacoepidemiology and drug safety 30 (6) (2021)
Kui Huang, Terri Madison, Beatrice Wehler, Marcello Tiseo, Keith D Wilner, Jingping Mo
Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe. Pharmacology research & perspectives 8 (2) (2021)